Apollomics Inc. (APLM)
Nasdaq: APLM · Pharmaceutical Preparations · Foster City, CA · filing with the SEC since 2022
Who runs Apollomics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Chen Hung-Wen
Chief Executive Officer. First filing Mar 2026, latest Sep 17, 2026, 1 filing in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lin Peter Kuan-How | Chief Financial Officer | Mar 2026 | Sep 24, 2026 | none |
| Chen Yi-Kuei | Chief Operating Officer | Mar 2026 | Sep 24, 2026 | none |
| Chen Hung-Wen | Chief Executive Officer | Mar 2026 | Sep 17, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Yen Hung Hsien | director | Jul 2026 | Sep 24, 2026 | none |
| Chen Hong-Jung | director | Mar 2026 | Sep 17, 2026 | none |
| Huang Ya-Chi | director | Mar 2026 | Sep 17, 2026 | none |
| Tsai Hsien-Shu | director | Mar 2026 | Sep 17, 2026 | none |
| Chu Yi-An | director | Mar 2026 | Jun 16, 2026 | none |
| Jan Chen-Huan | director | Mar 2026 | Jun 16, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.